Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A streptococcus

Microbial Pathogenesis

Volumn 49, Issue 6, 2010, Pages 336-347

  Olsen, Randall J ^a,b   Ashraf, Madiha ^b   Gonulal, Vedia E ^a   Ayeras, Ara A ^a   Cantu, Concepcion ^a   Shea, Patrick R ^a   Carroll, Ronan K ^a   Humbird, Tammy ^c   Greaver, Jamieson L ^c   Swain, Jody L ^d   Chang, Ellen ^a   Ragasa, Willie ^a   Jenkins, Leslie ^b   Lally, Kevin P ^e   Blasdel, Terry ^c   Cagle, Philip ^b   Musser, James M ^a,b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Group A Streptococcus; Invasive infection; Lower respiratory tract; Non human primate model; Pneumonia

Indexed keywords

C REACTIVE PROTEIN; CYCLOPHILIN A; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 8; METAL TRANSPORTER OF STREPTOCOCCUS A; OLIGOSACCHARIDE BINDING PROTEIN; SECRETED PROTEASE B; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BLOOD ANALYSIS; BRONCHOPNEUMONIA; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MACACA; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION;

ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOPNEUMONIA; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; LUNG; MACACA FASCICULARIS; MALE; MONKEY DISEASES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

ANIMALIA; MACACA; MACACA FASCICULARIS; PRIMATES; STREPTOCOCCUS SP. 'GROUP A';

EID: 77957805304     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2010.06.012     Document Type: Article

References (58)

1. Olsen R.J., Shelburne S.A., Musser J.M. Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol 2009, 11:1-12.
2. Mehta S., McGeer A., Low D.E., Hallett D., Bowman D.J., Grossman S.L., et al. Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest 2006, 130:1679-1686.
3. Lamagni T.L., Neal S., Keshishian C., Alhaddad N., George R., Duckworth G., et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg Infect Dis 2008, 14:202-209.
4. O'Loughlin R.E., Roberson A., Cieslak P.R., Lynfield R., Gershman K., Craig A., et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007, 45:853-862.
5. Demers B., Simor A.E., Vellend H., Schlievert P.M., Byrne S., Jamieson F., et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993, 16:792-800.
6. Muller M.P., Low D.E., Green K.A., Simor A.E., Loeb M., Gregson D., et al. Clinical and epidemiologic features of group a streptococcal pneumonia in Ontario, Canada. Arch Intern Med 2003, 163:467-472.
7. Al-Kaabi N., Solh Z., Pacheco S., Murray L., Gaboury I., Le Saux N. A comparison of group A Streptococcus versus Streptococcus pneumoniae pneumonia. Pediatr Infect Dis J 2006, 25:1008-1012.
8. Hollm-Delgado M.G., Allard R., Pilon P.A. Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001. Emerg Infect Dis 2005, 11:77-82.
9. Tyrrell G.J., Lovgren M., Kress B., Grimsrud K. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol 2005, 43:1678-1683.
10. Ekelund K., Skinhoj P., Madsen J., Konradsen H.B. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect 2005, 11:569-576.
11. MacCallum W.G. The pathology of the pneumonia in the United States Army camps during the Winter 1917-1918 1919, Rockefeller Institute for Medical Research, New York.
12. Basiliere J.L., Bistrong H.W., Spence W.F. Streptococcal pneumonia. Recent outbreaks in military recruit populations. Am J Med 1968, 44:580-589.
13. Gray G.C., Callahan J.D., Hawksworth A.W., Fisher C.A., Gaydos J.C. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis 1999, 5:379-385.
14. Crum N.F., Russell K.L., Kaplan E.L., Wallace M.R., Wu J., Ashtari P., et al. Pneumonia outbreak associated with group A Streptococcus species at a military training facility. Clin Infect Dis 2005, 40:511-518.
15. Schwartz B., Elliott J.A., Butler J.C., Simon P.A., Jameson B.L., Welch G.E., et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992, 15:277-284.
16. Gamba M.A., Martinelli M., Schaad H.J., Streuli R.A., DiPersio J., Matter L., et al. Familial transmission of a serious disease-producing group A streptococcus clone: case reports and review. Clin Infect Dis 1997, 24:1118-1121.
17. Keefer C.S., Rammelkamp C.H. Hemolytic streptococcal pneumonia and empyema; a study of 55 cases with special reference to treatment. Ann Intern Med 1941, 14:1533-1550.
18. Lamagni T.L., Neal S., Keshishian C., Hope V., George R., Duckworth G., et al. Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004. Clin Microbiol Infect 2008, 14:1002-1009.
19. Barnham M., Weightman N., Anderson A., Pagan F., Chapman S. Review of 17 cases of pneumonia caused by Streptococcus pyogenes. Eur J Clin Microbiol Infect Dis 1999, 18:506-509.
20. Agniswamy J., Lei B., Musser J.M., Sun P.D. Insight of host immune evasion mediated by two variants of group a Streptococcus Mac protein. J Biol Chem 2004, 279:52789-52796.
21. Sumby P., Zhang S., Whitney A.R., Falugi F., Grandi G., Graviss E.A., et al. A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun 2008, 76:978-985.
22. Sumby P., Tart A.H., Musser J.M. A non-human primate model of acute group A Streptococcus pharyngitis. Methods Mol Biol 2008, 431:255-267.
23. Virtaneva K., Porcella S.F., Graham M.R., Ireland R.M., Johnson C.A., Ricklefs S.M., et al. Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. Proc Natl Acad Sci U S A 2005, 102:9014-9019.
24. Olsen R.J., Sitkiewicz I., Ayeras A.A., Gonulal V.E., Cantu C., Beres S.B., et al. Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A 2010, 107:888-893.
25. Olsen R.J., Kobayashi S.D., Ayeras A.A., Ashraf M., Graves S.F., Ragasa W.P., et al. Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in non-human primates. Am J Pathol 2010, 176:1346-1354.
26. Beres S.B., Richter E.W., Nagiec M.J., Sumby P., Porcella S.F., DeLeo F.R., et al. Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A 2006, 103:7059-7064.
27. Beres S.B., Sylva G.L., Barbian K.D., Lei B., Hoff J.S., Mammarella N.D., et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A 2002, 99:10078-10083.
28. Farver C.F. Bacterial diseases. Pulmonary pathology 2002, 167-201. Churchill Livingstone, Philadelphia. D.S. Zander, C.F. Farver (Eds.).
29. Bisno A.L., Stevens D.L. Streptococcus pyogenes. Principles and practice of infectious diseases 2010, 2593-2610. Elsevier, Philadelphia. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
30. Shea P.R., Virtaneva K., Kupko J.J., Porcella S.F., Barry W.T., Wright F.A., et al. Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus. Proc Natl Acad Sci U S A 2010, 107:4693-4698.
31. Olsen R.J., Musser J.M. Molecular pathogenesis of necrotizing fasciitis. Annu Rev Pathol 2010, 5:1-31.
32. Moyron-Quiroz J.E., Rangel-Moreno J., Kusser K., Hartson L., Sprague F., Goodrich S., et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004, 10:927-934.
33. Voyich J.M., Sturdevant D.E., Braughton K.R., Kobayashi S.D., Lei B., Virtaneva K., et al. Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 2003, 100:1996-2001.
34. Kobayashi S.D., Braughton K.R., Whitney A.R., Voyich J.M., Schwan T.G., Musser J.M., et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A 2003, 100:10948-10953.
35. Centers for Disease Control and Prevention Outbreak of group A streptococcal pneumonia among Marine Corps Recruits - California, November 1-December 20, 2002. JAMA 2003, 289:1373-1375.
36. Morens D.M., Taubenberger J.K., Fauci A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008, 198:962-970.
37. Morens D.M., Taubenberger J.K., Fauci A.S. The persistent legacy of the 1918 influenza virus. N Engl J Med 2009, 361:225-229.
38. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009, 58:1071-1074.
39. Gill J.R., Sheng Z., Ely S.F., Guinee D.G., Beasley M.B., Suh J., et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010, 134:E1-E9.
40. Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902.
41. Miller R.R., Markewitz B.A., Rolfs R.T., Brown S.M., Dascomb K.K., Grissom C.K., et al. Clinical findings and demographic factors associated with intensive care unit admission in Utah due to 2009 novel influenza A (H1N1) infection. Chest 2010, 137:752-758.
42. Flynn J.L., Capuano S.V., Croix D., Pawar S., Myers A., Zinovik A., et al. Non-human primates: a model for tuberculosis research. Tuberculosis 2003, 83:116-118.
43. Fuller C.L., Flynn J.L., Reinhart T.A. In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect Immun 2003, 71:7023-7034.
44. Chang H.Y., Chen C.W., Chen C.Y., Hsuie T.R., Chen C.R., Lei W.W., et al. Successful treatment of diffuse lipoid pneumonitis with whole lung lavage. Thorax 1993, 48:947-948.
45. de Blic J. Pulmonary alveolar proteinosis in children. Paediatr Respir Rev 2004, 5:316-322.
46. Jeng M.J., Soong W.J., Lee Y.S. Effective lavage volume of diluted surfactant improves the outcome of meconium aspiration syndrome in newborn piglets. Pediatr Res 2009, 66:107-112.
47. Wang S.M., Lu I.H., Lin Y.L., Lin Y.S., Wu J.J., Chuang W.J., et al. The severity of Streptococcus pyogenes infections in children is significantly associated with plasma levels of inflammatory cytokines. Diagn Microbiol Infect Dis 2008, 61:165-169.
48. Monton C., Torres A., El-Ebiary M., Filella X., Xaubet A., de la Bellacasa J.P. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999, 27:1745-1753.
49. Kobasa D., Jones S.M., Shinya K., Kash J.C., Copps J., Ebihara H., et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445:319-323.
50. Philipp M.T., Purcell J.E., Martin D.S., Buck W.R., Plauche G.B., Ribka E.P., et al. Experimental infection of rhesus macaques with Streptococcus pneumoniae: a possible model for vaccine assessment. J Med Primatol 2006, 35:113-122.
51. Hayden F.G., Fritz R., Lobo M.C., Alvord W., Strober W., Straus S.E. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 1998, 101:643-649.
52. Kirby A.C., Coles M.C., Kaye P.M. Alveolar macrophages transport pathogens to lung draining lymph nodes. J Immunol 2009, 183:1983-1989.
53. Thulin P., Johansson L., Low D.E., Gan B.S., Kotb M., McGeer A., et al. Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med 2006, 3:e53.
54. Beres S.B., Sylva G.L., Sturdevant D.E., Granville C.N., Liu M., Ricklefs S.M., et al. Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. Proc Natl Acad Sci U S A 2004, 101:11833-11838.
55. Sitkiewicz I., Nagiec M.J., Sumby P., Butler S.D., Cywes-Bentley C., Musser J.M. Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. Proc Natl Acad Sci U S A 2006, 103:16009-16014.
56. Nakakuki S. The bronchial tree and lobular division of the crab-eating monkey (Macaca fascicularis) lung. J Vet Med Sci 1994, 56:567-571.
57. Shelburne S.A., Olsen R.J., Suber B., Sahasrabhojane P., Sumby P., Brennan R.G., et al. A combination of independent transcription regulators shapes bacterial virulence gene expression during infection. PLoS Pathog 2010, 6:e1000817.
58. Graham M.R., Virtaneva K., Porcella S.F., Gardner D.J., Long R.D., Welty D.M., et al. Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection. Am J Pathol 2006, 169:927-942.